Previous Close | 1.1500 |
Open | N/A |
Bid | 0.0000 |
Ask | 2.8000 |
Strike | 55.00 |
Expire Date | 2024-12-20 |
Day's Range | 1.1500 - 1.1500 |
Contract Range | N/A |
Volume | |
Open Interest | 1 |
Oppenheimer & Co. Inc. (Oppenheimer) — a leading investment bank, wealth manager and a subsidiary of Oppenheimer Holdings (NYSE: OPY) — announced today that Kunal Bhatia joined as a Managing Director in the firm's Healthcare Investment Banking Group. He will be based in New York and report to Michael Margolis, R.Ph, Oppenheimer's Co-Head of Healthcare and Head of Healthcare Life Sciences Investment Banking.
Key Insights Insiders appear to have a vested interest in Oppenheimer Holdings' growth, as seen by their sizeable...
Oppenheimer Europe (Oppenheimer) — a subsidiary of Oppenheimer Holdings, the leading investment bank and wealth manager (NYSE: OPY) — announced today a further expansion of its European investment banking footprint with the addition of Martin Chamberlin.